Mark Hamann to Enzyme Inhibitors
This is a "connection" page, showing publications Mark Hamann has written about Enzyme Inhibitors.
Connection Strength
0.453
-
Forrestiacids A and B, Pentaterpene Inhibitors of ACL and Lipogenesis: Extending the Limits of Computational NMR Methods in the Structure Assignment of Complex Natural Products. Angew Chem Int Ed Engl. 2021 10 04; 60(41):22270-22275.
Score: 0.149
-
A Chemical Investigation of the Leaves of Morus alba L. Molecules. 2018 04 26; 23(5).
Score: 0.118
-
In silico investigation of lavandulyl flavonoids for the development of potent fatty acid synthase-inhibitory prototypes. Biochim Biophys Acta Gen Subj. 2017 Jan; 1861(1 Pt A):3180-3188.
Score: 0.105
-
Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases. Life Sci. 2005 Dec 22; 78(5):442-53.
Score: 0.050
-
Slow-Binding Inhibition of Mycobacterium tuberculosis Shikimate Kinase by Manzamine Alkaloids. Biochemistry. 2018 08 14; 57(32):4923-4933.
Score: 0.030